Galangin is a flavonoid from the root of Alpinia officinarum. It has novel anticancer properties. In the current study, ovarian cancer cells SKOV3 were treated with galangin alone, galangin combined with Gold nanoparticles (AuNPs) and AuNPs alone, and cytotoxic activity of these agentswas investigated using MTT viability assay. The expression of apoptosis-related genes p53, caspase-8 was studied using Real time PCR assay. Galangin was tested at different concentrations. AuNPs concentrations were 6.25,12.5, 25, 50 and 100 µg/ml. The study of gene expression showed significant effects on p53, caspase8 in ovarian carcinoma cells. The results of the current study refer to galangin-AuNPs combination is synergistic against to ovarian carcinoma to induce cytotoxicity and cell death via apoptosis, this mechanism enhancing expression of p53, caspase-8. The effects of galangin, AuNPs,combination therapy have potential clinicaluse in the future and could be alternative way to the conventional chemotherapy drug.
REFERENCES
1.
G.
Chornokur
, E.K.
Amankwah
, J.M.
Schildkraut
, C.M.
Phelan
Gynecologic oncology
129
, 258
–64
(2013
).2.
M. S.
Jabir
, A. A.
Taha
, U.I.
Sahib
., Artif. Cells Nanomed. Biotechnol.
46
, 345
–355
(2018
).3.
K.S.
Khashan
, M.S.
Jabir
, F.A.
Abdulameer
, “Preparation and characterization of copper oxide nanoparticles decorated carbon nanoparticles using laser ablation in liquid
” (Journal of Physics: Conference Series
, 2018
), pp. 012100
4.
W. K.
Abdulkadhim
, M.
Jabir
, U.
Nayef
. Research Journal of Biotechnology
14
, 89
–93
(2019
).5.
S. A.
Ibraheem
, H. A.
Kadhem
, S.
Al Hadeethi
, M. S.
Jabir
, Romanian Biotechnological Letters
24
, 286
–293
(2019
).6.
Z.
Taqi
, M. A. J.
Hamad
, M.S.
Jabir
, Research Journal of Biotechnology
14
, 156
–159
(2019
).7.
Z.
Al-Hilli
, Al-Shammari A.
Majeed
, E.
Al-Jumaily
, N.Y.
Yaseen
“First Scientific Conference on Nanotechnology”, Advanced Material and Their applications
, At: University of Technology
; Baghdad, Iraq
168
–80
. (2009
).8.
R.
Abo-Altemen
, Al-Shammari A.
Majeed
, Shawkat MEnergy Procedia
157
, 1462
–74
(2019
).9.
K. S.
Khashan
, M. S.
Jabir
, F.A.
Abdulameer
., Surface Review and Letters
1950078
. (2019
).10.
M.
Bacanlı
, A.A.
Başaran
, N.
Başaran
, Polyphenols: Prevention and Treatment of Human Disease
(Second Edition): Academic Press
433
–8
(2018
).11.
I. H
Ali
, M. S.
Jabir
, H.
Al-Shmgani
, G.M.
Sulaiman
, A.H.
Sadoon
, ”Pathological And Immunological Study On Infection With Escherichia Coli In ale BALB/c mice
.” (Journal of Physics: Conference Series
, 2018
), pp. 1003012009
.12.
13.
M. S.
Jabir
, U. M.
Nayef
, W. K. Abdul
Kadhim
, Nano Biomedicine and Engineering
11
, 56
–63
(2019
).14.
15.
J.
Zhao
, V.
Castranova
J Toxicol Environ Health B Crit Rev
14
, 593
–632
(2011
).16.
I.
Alsaedi
, Z.
Taqi
, A. M. Abdul
Hussien
, G. M
Sulaiman
, M. S.
Jabir
, Materials Research Express
6
095413
(2019
).17.
A.
Gerber
, M.
Bundschuh
, D.
Klingelhofer
, D.A.
Groneberg
, Journal of occupational medicine and toxicology
8
32
–38
(2013
).18.
W. K.
Kadhim
, U. M.
Nayef
, M. S.
Jabir
, Surf. Rev. Lett.
1950079
(2019
).19.
H. A.
Kadhem
, S. A.
Ibraheem
, M. S.
Jabir
, A. K.
Afraa
, Nano Biomed. Eng
11
, 35
–43
(2019
).20.
D.
Latha
, P.
Prabu
, C.
Arulvasu
, R.
Manikandan
, S.
Sampurnam
, V.
Narayanan
Asian Pacific Journal of Tropical Biomedicine
8
, 540
. (2018
).21.
A. H.
Younus
, S.
Ahmer
, M. S.
Jabir
, Research Journal of Biotechnology
14
, 131
–133
(2019
).22.
M. M.
Radhi
, H. N.
Abdullah
, M. S.
Jabir
, A. J.
Emad
, Nano Biomed. Eng.
9103
–106
(2017
).23.
24.
Saja H
Ali
, M S.
Ghassan
, MF Al-Halbosiy
Mohammad
, S J.
Majid
, H. H.
Anaheed
, Artif. Cells Nanomed. Biotechnol.
47
, 378
–394
(2019
).25.
Z. U.
Ali
, M. S.
Jabir
, A. M.
Al-Shammari
., Research Journal of Biotechnology
, 79
–82
(2019
).26.
A. Al-Shammari
Majeed
, Salman
M. I.
, Saihood
Y.D.
, Yaseen
N.Y.
, Raed
K.
, Shaker
H.K
Biomedicines
4
, 3
(2016
).27.
Jabir
M. S.
, M S. Sulaiman
Ghassan
., Z. J.
Taqi
., D.
Li
., Microbes and infection
, 20
, 89
–100
(2018
).28.
S. J.
Majid
, A. A.
Taha
., U. I.
Sahib
., Z. J.
Taqi
., A. M.
Al-Shammari
., A. S.
Salman
., Mater. Sci. Eng., C
94
, 949
–964
(2019
).29.
G. M.
Sulaiman
, M. S.
Jabir
, H. H.
Anaheed
, Artif. Cells Nanomed. Biotechnol. Artificial Cells biotechnology
46
, 708
–720
(2018
).30.
K. S
Khashan
, M. S.
Jabir
, F. A.
Abdulameer
, Mater. Res. Express
5
, 035003
(2018
).31.
M. H.
Mohammad
, Al-Shammari A.
Majeed
, Al-Juboory
A. A.
, Yaseen
N.Y.
Stem cells and cloning: advances and applications
9
, 1
(2016
).32.
S. H.
Ali
, G.M.
Sulaiman
, M. F.
Al-Halbosiy
, M.S.
Jabir
, A. H.
Hameed
, Artif. Cells Nanomed. Biotechnol. Artificial Cells biotechnology
47
, 378
–394
(2019
).33.
S.
Albukhaty
, H.
Naderi-Manesh
, T.
Taki
, M.
Jabir
, S.
Jabir
, Artificial cells, nanomedicine, and biotechnology
46
, S125
–S132
(2018
).34.
M. S.
Jabir
, U. M.
Nayef
, K. H.
Jawad
, Z. J.
Taqi
, N. R.
Ahmed
, ”Porous silicon nanoparticles prepared via an improved method: a developing strategy for a successful antimicrobial agent against Escherichia coli and Staphylococcus aureus
.” (IOP Conference Series: Materials Science and Engineering
, 2018
) pp 012077
.
This content is only available via PDF.
© 2020 Author(s).
2020
Author(s)
You do not currently have access to this content.
